LGLVX
Price
$43.37
Change
+$0.84 (+1.98%)
Updated
Mar 11 closing price
Net Assets
5.94B
VIGRX
Price
$191.56
Change
-$0.44 (-0.23%)
Updated
Mar 11 closing price
Net Assets
282.6B
Ad is loading...

LGLVX vs VIGRX

Header iconLGLVX vs VIGRX Comparison
Open Charts LGLVX vs VIGRXBanner chart's image
Lord Abbett Growth Leaders R6
Price$43.37
Change+$0.84 (+1.98%)
VolumeN/A
Net Assets5.94B
Vanguard Growth Index Investor
Price$191.56
Change-$0.44 (-0.23%)
VolumeN/A
Net Assets282.6B
LGLVX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGLVX vs. VIGRX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLVX is a Hold and VIGRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 283B vs. LGLVX (5.94B). VIGRX pays higher dividends than LGLVX: VIGRX (0.35) vs LGLVX (0.00). LGLVX was incepted earlier than VIGRX: LGLVX (10 years) vs VIGRX (32 years). LGLVX (0.59) is less costly to investors than VIGRX (0.17). LGLVX is a more actively managed with annual turnover of: 94.00 vs. VIGRX (5.00). LGLVX has a lower initial minimum investment than VIGRX: LGLVX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 10.52 vs. LGLVX (7.40). VIGRX return over 5 years is better than : 149.70 vs. LGLVX (72.75).
LGLVXVIGRXLGLVX / VIGRX
Total Expense Ratio0.590.17347%
Annual Report Gross Expense Ratio0.590.17347%
Fund Existence10 years32 years-
Gain YTD-15.194-9.130166%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.94B283B2%
Annual Yield % from dividends0.000.35-
Returns for 1 year7.4010.5270%
Returns for 3 years28.7644.1265%
Returns for 5 years72.75149.7049%
Returns for 10 yearsN/A250.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCYC10.210.42
+4.29%
Bicycle Therapeutics plc
UPC0.14N/A
+3.49%
Universe Pharmaceuticals Inc
HCM15.680.25
+1.62%
HUTCHMED (China) Limited
PEBK26.40-0.01
-0.04%
Peoples Bancorp of North Carolina
DGX168.15-4.97
-2.87%
Quest Diagnostics